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Background: Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is be-
lieved to play a major role in acetaldehyde detoxification in the ethanol
metabolism. The alcohol sensitivity is associated with a mutant allele of the
ALDH2 gene (ALDH2*2), which results in a substitution of Glu 487 to Lys,
acting in a dominant negative fashion. Our molecular epidemiologic anal-
ysis has shown the association of Alzheimer’s disease (AD) with
ALDH2*2 allele. The concentration of lipid peroxides (LPO) was signifi-
cantly higher in defective ALDH2 females than nondefective ones, sug-
gesting that ALDH2 functions as a protector against oxidative stress.
Indeed, ALDH2 detoxifies reactive aldehydes, such as 4-hydroxyl-2-non-
enal (4-HNE), that are derived from LPO. Objective(s): To clarify a role
of ALDH2-deficiency in age-associated neurodegenerative diseases such
as AD, we examined physiological changes and learning and memory
impairments that occur in transgenic mice expressing ALDH2*2 in the
brain. Methods: We constructed transgenic mice by introducing the
mouse-version of the ALDH2*2 gene, and named the resultant mice DAL
(Dominant negative of ALDH2) mice. Results: Female DAL mice exhib-
ited no particular abnormality on physical examinations compared with
control C57BL/6 mice when observed until 18 months after birth. How-
ever, primary cultured neocortical cells from DAL mouse embryos exhib-
ited increase in vulnerability to 4-HNE. Therefore, autopsy of the brain was
performed in 6-month-old mice, but no difference compared with the brain
of control C57BL/6 mice was noted, whereas in 18-month-old DAL mice,
signs of neurodegeneration such as atrophy of the hippocampus and asso-
ciated loss of pyramidal cells and activation of glial cells were observed.
These changes were sporadically observed from 12-month-old and in-
creased with aging. The old-aged DAL mice also developed prominent
deficits in special memory in the Morris water-maze test, whereas young
DAL mice (6-month) looked normal. Accumulation of oxidative stress in
the brain of DAL mice will be further discussed. Conclusions: Brain
degeneration and decline in spatial cognitive ability in DAL mice are
considered to be due to decrease in resistance to oxidative stress. Analysis
of these mice will clarify the relationship between lesions characteristic of
AD and oxidative stress.
P3-366 THE COMPLEXATION OF AMYLOID- WITH
HEME FORMS A PEROXIDASE: MECHANISM OF
NEUROTOXICITY IN ALZHEIMER’S DISEASE
Hani Atamna, Kathleen Boyle, Children’s Hospital Research Center,
Oakland, Oakland, CA, USA. Contact e-mail: hatamna@chori.org
Background: The molecular mechanism by which Amyloid- (A) pep-
tide causes the neurodegeneration in Alzheimer’s disease (AD) is not
known. We previously proposed that excessive A binds to regulatory
heme, triggering functional heme deficiency (HD), causing the key cyto-
pathologies of AD including mitochondrial dysfunction, loss of complex
IV, iron accumulation, and oxidative stress (Atamna et al. 2004, PNAS).
Objectives: In the current study we searched for additional evidence that
Ab binding to regulatory heme is the mechanism by which A causes HD.
Methods: The experiments included techniques of tissue culture, biochem-
istry, radiobiology, and HPLC. Results: We found that heme binds to A
forming an A-heme complex. We also found that A induces heme
synthesis and iron uptake in human neuroblastoma cells, which provides
strong support that A triggers HD. Interestingly, we also found that the
A-heme complex is a peroxidase, which catalyzes the oxidation of sero-
tonin and DOPA by H2O2. Curcumin, which lowers oxidative damage in
the brain in a mouse model for AD, inhibits the A-heme peroxidase.
Conclusion: The binding of A to heme supports a unifying mechanism
by which elevated levels of A induces HD, causes oxidative damage to
macromolecules, and depletes specific neurotransmitters. The relevance of
the depletion of regulatory heme by excessive A and A-heme peroxi-
dase to mitochondrial dysfunction, oxidative stress, neurotoxicity and other
cytopathologies of AD will be discussed.
P3-367 ASSESSMENT OF ALTERED BLOOD/BRAIN IRON
METABOLISM AS A RISK FACTOR FOR THE
DEVELOPMENT OF ALZHEIMER’S DISEASE
Claudius Mueller1,2, Shino Magaki1, Wolff M. Kirsch1, 1Loma Linda
University, Loma Linda, CA, USA; 2Fachbereich Biologie, Chemie,
Pharmazie der Freien Universitaet Berlin, Berlin, Germany. Contact
e-mail: cmueller@llu.edu
Background: Iron regulatory protein-2 (IRP-2), a post-transcriptional reg-
ulator of proteins responsible for iron uptake and storage, has shown
abnormal localization in Alzheimer’s Disease (AD) brain. Moreover,
IRP-2 knockout mice accumulate higher iron levels in certain brain regions
followed by axonal degeneration. Objectives: To address the role of
brain/blood iron perturbation in the pathogenesis of AD two groups of
elderly participants, one cognitively intact and the other mildly cognitively
impaired (MCI) have been studied longitudinally for changes in level and
function of IRP-2 in peripheral blood. Methods: Over the past 21 months
whole blood RNA and serum samples were obtained from 28 control and
76 amnestic multiple-domain MCI participants. Quantitative Realtime
PCR (QPCR) was used to investigate expression levels of IRP-2. To assess
the functionality of IRP-2, the expression of three alternative splice forms
of the divalent metal transporter 1 (DMT1), one of which contains an iron
response element by which IRP-2 controls its translation and two of which
do not, is being evaluated. Results: Through nested PCR and DNA se-
quencing we were able to identify several alternative splicing variants of
IRP-2 whose function and possible correlation to AD is currently being
assessed in relation to participant’s clinical course. QPCR done on RNA
samples of nine participants has shown a differential expression of IRP-2
between MCI and either control or progressive MCI (PMCI) patients. A
larger scale study involving 20 control, 20 MCI and 13 PMCI age and
gender matched participants is currently under way to confirm that finding.
Conclusions: To our knowledge, this is the first report on the identification
of IRP-2 splice variants. The significance of these in the face of AD is
under current investigation. Furthermore, we were able to show expression
differences of IRP-2 between MCI and either control or PMCI patients.
This finding will be confirmed by a larger study to permit final conclusions
as to its significance. Regarding the function of IRP-2, final experiments
are currently being done to compare the ratios of DMT1-IRE to DMT1-
nonIRE between different stages of cognitive impairment. This research
was funded by NIH Grant #AG20948.
P3-368 ENDOGENOUS HUMAN APP POSSESSES
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Background: Amyloid precursor protein (APP) is a type-1 transmembrane
metal-binding protein with oxidase activity. Candidate substrates include
ferrous iron and cholesterol. We have recently identified a region of APP
with homology to the ferritin H subunit in residues 250-273 in APP-695
that has significant ferroxidase activity. Since APP also possesses a copper-
binding domain at the amino terminus whose structure has recently been
solved, it is possible that the ferroxidase activity of APP might be copper
dependent, like ceruloplasmin. Objective: To characterize the oxidase
activity of APP purified from normal human plasma and various cell lines.
The impact of urea denaturation, as well as copper supplementation and
deprivation on APP oxidase activity were also investigated. Methods: APP
and ceruloplasmin were purified from human plasma, neuronal cell lines
(M17 and SY5Y), fibroblasts and hepatocytes (HepG2) using anion-ex-
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change column chromatography, SDS-PAGE and electroelution. Activities
from these partially purified preparations were compared with purified
recombinant APP751 expressed in yeast, and ceruloplasmin obtained from
commercial sources. Oxidative activity was characterized using various
substrates (including PPD; p-Phenylenediamine dihydrochloride) and Fe2
oxidation, in the presence and absence of Cu2 and chelators. Results and
Conclusion: Plasma APP and ceruloplasmin separated by electroelution
both readily oxidized PPD. Cellular APP derived from neuronal (M17 and
SY5Y) and hepatic (HepG2) cell lines also oxidized PPD, indicating a
ubiquitous activity. Moreover, the oxidase activity of APP is not apparently
dependent upon delivery of copper by the copper transporter ATP7A
(Menkes protein) as activity was still detected with APP derived from
ATP7A-null fibroblast. As the PPD oxidase activity of APP does not
require Cu2, it is mechanistically more similar to that of ferritin than that
of ceruloplasmin.
P3-369 INTRANEURONAL AMYLOID-42 MAY SILENCE
OXIDATIVE STRESS IN ALZHEIMER’S DISEASE
Akihiko Nunomura1, Shigeru Chiba1, Haruyasu Yamaguchi2,
Mark A. Smith3, George Perry3, 1Department of Psychiatry and
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Background: A growing body of evidence suggests an initial role of intran-
euronal accumulation of amyloid- (A) in the pathological cascade of Alz-
heimer’s disease (AD), but on the other hand, we have reported that oxidative
stress is one of the earliest events in vulnerable neurons of AD. Indeed, both
intraneuronal A accumulation and oxidative stress precede extraneuronal
deposition of A plaque in patients with Down syndrome and in transgenic
mice models of AD, which suggests a possible connection between the two
events. Objective(s): To investigate the relationship between the levels of
intraneuronal A accumulation and oxidative damage to RNA in AD brains,
the latter of which was previously shown to parallel oxidative damage to
protein. Methods: Immunocytochemically, A40, A42 and the oxidized
RNA nucleoside, 8-hydroxyguanosine (8OHG) were identified in postmortem
tissue sections of the hippocampal region from 16 cases of AD (age 65-93
years). Results: Intraneuronal A42 and 8OHG immunoreactions were ob-
served in the hippocampal pyramidal neurons in all the subjects, while 8OHG-
positive neurons were more widely distributed compared with A42-positive
neurons. Intraneuronal A40 immunoreaction was faint in most of the sub-
jects. The QCB42 antibody (Biosource) showed the same pattern and level of
A42 immunoreaction in the neuronal cytoplasm that the MBC42 antibody
(H.Y.) showed, while the former recognizes both monomeric and oligomeric
A42 species and the latter recognizes mainly monomeric A42. However,
the antibody specific to A oligomers (provided by Dr. C. Glabe) hardly
immunostained the neuronal cytoplasm, suggesting that the neuronal cytoplas-
mic A42 observed in this study might be mainly monomeric. Relative density
measurements revealed an inverse relationship between intraneuronal A42
and 8OHG immunoreactivities (r   0.61, p  0.02), while there was no
significant relationship between intraneuronal A40 and 8OHG immunoreac-
tivities. Conclusions: Together with recent evidence that A possibly acts as
an antioxidant through its capability to capture redox metal ions, these results
suggest that intraneuronal accumulation of A42, especially the monomeric
form, is related to a compensatory response to neuronal oxidative stress in AD.
We suggest that excessive removal of A may lead to increased, rather than
decreased, neuronal oxidative damage in AD.
P3-370 APOE GENOTYPE HAS NO INFLUENCE IN
PLATELET AND ERYTHROCYTE OXIDATIVE
STATE
Tania Marcourakis1, Vale´ria S. Bahia1, Elisa M. Kawamoto1,
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Brazil; 2Federal University of Minas Gerais, Minas Gerais, Brazil.
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Background: In a previous study, we showed increased platelet and
erythrocyte oxidative stress in aging and Alzheimer	s Disease (AD)
(Kawamoto et al, Neurobiol Aging, 26:857-64, 2005). ApoEs are antiox-
idant glycoproteins, and ApoE4 has lower antioxidant capacity and is a
susceptibility factor for sporadic AD. Objective(s): To evaluate the influ-
ence of APOE genotype in oxidative stress production in aging and AD.
Methods: We evaluated 32 elderly subjects without dementia (19 women,
70.16.3 y) and 49 patients with probable AD (33 women, 73.27.3 y).
TBARS and cGMP content and nitric oxide synthase (NOS), superoxide
dismutase (SOD) and Na,K-ATPase activities were compared between
individuals with and without APOE 4 allele, using unpaired Student “t”
test. Results: The following results were found: 1) 62% of AD patients and
29% of controls were carriers of at least one 4 allele. 2) Significant
statistical difference between controls and AD was observed in TBARS
content (p 0,0001) and in NOS (p 0,005) and Na,K-ATPase activities
(p 0,0005). 3) We did not find any difference (p0.05) between indi-
viduals with and without 4 allele in any of the variables studied in AD
patients. In the control group, non-4 allele carriers showed higher SOD
activity than carriers (p 0,05). 4) When the analysis were performed
using only APOE genotype, independently of group, 4 allele carriers
showed higher NOS activity than non-carriers (p 0,05). Conclusions:
APOE 4 allele carriers did not show important increase in platelet and
erythrocyte oxidative stress markers than do non-carriers. Therefore,
APOE genotype was not directly related with the oxidative state in this
sample.
Supported by: FAPESP.
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IDIBAPS, Barcelona, Spain. Contact e-mail: acibam@iibb.csic.es
Background: The pathogenesis of Alzheimer disease is not completely
understood at present, although the generation of toxic beta-amyloid pep-
tide (A) is thought to play a prominent role. One of the cytotoxic effects
of the A is reactive oxygen species (ROS) overgeneration. Although, the
exact mechanisms of this process are not well defined, emerging evidence
points to mitochondria as a source for A-induced ROS generation. More-
over, disturbances in cholesterol homeostasis promote the formation and
deposition of A and the progression of AD. Recent findings from our
laboratory reveal that cholesterol enrichment of mitochondria depletes
selectively mitochondrial glutathione (mGSH), a major defense against
ROS generated from mitochondria. Objectives: The aim of this work was
to study how mGSH regulates the oxidative stress and the apoptotic
pathways triggered by A and to analyze its regulation by cholesterol in rat
brain mitochondria and in the human neuroblastoma cell line SH-SY5Y.
Results: Rat brain mitochondria were exposed to the A (1-42) peptide,
determining H2O2 generation and lipid peroxidation spectrofluorometri-
cally. A incubation elicited a burst of peroxide production within 2h.
However, mGSH depletion prior to A exposure potentiated the H2O2
generation (2-3 fold) and lipid peroxidation (5-10 fold) by A, which
correlated inversely with mGSH content. Furthermore, pre-treatment of
SH-SY5Y cells with (R,S)-3-hydroxy-4-pentenoate, which is biotrans-
formed into a Michael electrophyle in the mitochondrial matrix, caused
selective mGSH depletion (50-70%), sparing cytosol GSH. Exposure of
mGSH-depleted SH-SY5Y cells to A enhanced ROS generation and cell
death (40-70 %), compared to mGSH-repleted cells (20-30%) that was
prevented by the caspase inhibitor qVD-OPH. To ascertain the role of
cholesterol in modulating the susceptibility to A, we isolated brain mi-
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